Other News To Note
Wednesday, January 16, 2013
Opexa Therapeutics Inc., of The Woodlands, Texas, said it was notified by Nasdaq that it has regained full compliance with the minimum bid price continued listing requirement.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.